Nath Bio-Genes (India) Limited (BOM:537291)

Market Cap	3.06B -14.4%
Revenue (ttm)	4.45B +21.9%
Net Income	416.30M +7.9%
EPS	20.98 +3.3%
Shares Out	n/a
PE Ratio	7.34
Forward PE	n/a
Dividend	2.00 (1.24%)
Ex-Dividend Date	Aug 14, 2025

Volume	9,543
Open	170.50
Previous Close	172.55
Day's Range	157.20 - 172.00
52-Week Range	126.75 - 238.00
Beta	n/a
Analysts	Strong Buy
Price Target	n/a
Earnings Date	Jul 31, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jowar; and seeds for vegetables comprising chilli, okra, tomato, bitter gourd, and cucumber. It also provides crop protection supplements under the Win-ch...

• Industry: Agricultural Production Crops
• Founded: 1979
• Employees: 451
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 537291

Financial Performance

In fiscal year 2026, Nath Bio-Genes (India)'s revenue was 4.45 billion, an increase of 21.93% compared to the previous year's 3.65 billion. Earnings were 416.30 million, an increase of 7.85%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 20, 2026

Data Sources Report a data error